GLG Partners’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-14,323
Closed -$1.61M 383
2016
Q3
$1.61M Buy
+14,323
New +$1.65M 0.05% 308
2016
Q1
Sell
-7,380
Closed -$803K 420
2015
Q4
$803K Buy
+7,380
New +$845K 0.03% 340
2014
Q3
Sell
-32,836
Closed -$5.49M 428
2014
Q2
$5.49M Buy
+32,836
New +$5.84M 0.13% 175

Other funds holding CLB

GLG Partners's CLB Position: Q4 2016 in Review

GLG Partners sold out of Core Laboratories (CLB) in Q4 2016, closing a stake of 14,323 shares — an estimated $1.61M sold.

GLG Partners first reported a position in CLB in Q2 2014 and held it in 3 quarters. The position peaked at $5.49M in Q2 2014. 372 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

  • GLG Partners reported no remaining Core Laboratories position as of Q4 2016 after selling out during the quarter.
  • GLG Partners sold 14,323 Core Laboratories shares in Q4 2016, an estimated $1.61M.
  • GLG Partners first reported a position in Core Laboratories in Q2 2014 and held it in 3 quarters.
  • GLG Partners's Core Laboratories position peaked at $5.49M in Q2 2014.
  • 372 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on GLG Partners's 13F filing for Q4 2016, filed 14 Feb 2017.